attach
viru
cognat
host
cell
receptor
first
step
viral
infect
serv
key
determin
host
specif
tissu
tropism
pathogen
virus
singl
receptor
suffici
promot
infect
other
requir
addit
attach
factor
cell
entri
carbohydr
link
protein
lipid
receptor
recogn
numer
virus
facilit
attach
entri
carbohydr
typic
hijack
virus
group
three
class
sialyl
carbohydr
glycosaminoglycan
gag
group
antigen
hbga
glycosyl
protein
also
help
mediat
receptor
recognit
sialyl
carbohydr
ubiquit
express
among
vertebr
engag
numer
virus
includ
influenza
virus
orthoreovirus
human
coronavirus
cov
adenovirus
glycan
contain
sialic
acid
usual
found
termini
branch
glycosphingolipid
display
high
level
divers
divers
aris
possibl
sialic
acid
modif
acetyl
methyl
hydroxyl
sulfat
addit
differ
glycosidici
linkag
type
connect
sialic
acid
subsequ
carbohydr
residu
chain
although
glycosid
linkag
galactos
gal
galnac
common
type
found
sialoglycan
structur
degre
viru
host
rang
specif
determin
glycosid
linkag
type
seen
exampl
influenza
gag
repres
anoth
class
viru
glycan
receptor
attach
factor
recogn
exampl
herpesvirus
papillomavirus
linear
polysaccharid
built
repeat
unit
disaccharid
contain
amino
sugar
uron
acid
gal
promin
exampl
gag
chondroitin
sulfat
heparan
sulfat
typic
sever
gag
chain
coval
attach
via
serin
residu
core
protein
togeth
form
proteoglycan
produc
virtual
mammalian
import
characterist
gag
overal
neg
charg
confer
sulfat
uron
acid
carboxi
group
hbga
hand
neutral
termin
carbohydr
structur
glycan
chain
function
viral
attach
factor
norovirus
human
rotavirus
exampl
glycan
express
epitheli
cell
erythrocyt
also
secret
saliva
bodi
fluid
biosynthesi
carri
stepwis
addit
monosaccharid
specif
glycosyltransferas
fig
presenc
absenc
function
glycosyltransferas
gene
lead
differ
hbga
phenotyp
among
human
lead
differ
suscept
certain
viru
strain
expos
viru
surfac
area
engag
glycan
protein
receptor
may
also
target
antibodi
part
immun
respons
bind
antibodi
free
viru
particl
infect
cell
inhibit
viru
releas
host
cell
block
viral
transmiss
activ
effector
system
antibodi
term
neutral
refer
capabl
inhibit
viru
infect
direct
bind
antigen
vitro
antibodi
usual
bind
expos
structur
viru
surfac
high
affin
also
protect
cell
infect
interf
attach
cell
entri
protein
data
bank
pdb
contain
exampl
virus
viral
protein
structur
data
glycan
receptor
neutral
antibodi
bind
avail
due
technic
improv
field
structur
biolog
emerg
interest
glycobiolog
research
number
structur
ad
pdb
increas
past
year
investig
subset
structur
examin
extent
bind
glycan
receptor
antibodi
mediat
structur
determin
viru
surfac
four
virus
reovirus
influenza
virus
norovirus
cov
fig
chosen
exampl
belong
differ
viru
class
contain
protrud
multimer
viral
attach
protein
mediat
interact
glycan
time
provid
major
target
neutral
antibodi
wherea
three
glycan
type
use
receptor
virus
structur
data
avail
primarili
interact
therefor
focus
repres
two
interact
well
anoth
exampl
protein
serv
receptor
detail
comparison
bind
mode
antibodi
glycan
provid
insight
determin
glycan
antibodi
recognit
case
inform
design
improv
antivir
strategi
reovirus
member
reovirida
famili
enclos
ten
segment
ds
rna
within
two
concentr
protein
shell
although
virus
usual
caus
asymptomat
infect
human
recent
associ
develop
celiac
newborn
mice
reoviru
spread
intestin
major
organ
includ
liver
spleen
lung
heart
central
nervou
system
cn
three
reoviru
serotyp
repres
prototyp
strain
type
lang
type
jone
type
dear
differ
rout
spread
cell
tropism
respons
differ
diseas
pattern
cn
differ
link
gene
segment
encod
protein
outer
capsid
protein
homotrimer
protein
anchor
capsid
icosahedr
vertic
protrud
filament
stalk
globular
head
domain
initi
attach
viru
host
cell
mediat
bind
sialyl
carbohydr
receptor
follow
step
bind
protein
reovirus
bind
sialic
acid
receptor
use
entir
differ
region
protein
furthermor
two
strain
display
differ
hemagglutin
profil
indic
differ
glycan
specif
glycan
array
screen
identifi
oligosaccharid
portion
gangliosid
receptor
structur
analys
interact
glycan
reveal
site
lie
small
groov
head
domain
fig
termin
carbohydr
moieti
branch
tetrasaccharid
contribut
specif
carbohydr
receptor
identifi
thu
far
shown
studi
strain
bind
rang
differ
link
sialyl
glycan
within
stalk
observ
contact
form
sialic
acid
glycan
cap
although
strain
mostli
use
backbon
atom
hydrogen
bond
format
glycan
sialic
acid
function
group
engag
differ
way
exampl
sialic
acid
carboxyl
group
form
hydrogen
bond
gln
side
chain
case
salt
bridg
arg
case
bind
mutat
one
two
residu
involv
bind
suffici
abolish
reovirus
capabl
bind
glycan
still
infecti
sialic
strain
spread
rapidli
intestin
site
secondari
replic
substanti
strain
also
engag
proteinac
reoviru
receptor
name
junction
adhes
molecul
nogo
receptor
although
bind
conserv
region
interact
reoviru
known
structur
level
current
avail
data
support
model
interact
two
protein
receptor
follow
common
mechan
essenti
reoviru
infect
glycan
interact
promot
reoviru
spread
influenc
viral
cell
tropism
diseas
account
observ
differ
pathogen
reoviru
infect
lead
develop
neutral
antibodi
neutral
antibodi
identifi
three
outer
capsid
compon
antibodi
respons
usual
typic
elicit
antibodi
sever
region
protein
immunogen
differ
antibodi
use
identifi
distinct
function
domain
vivo
protect
diseas
occur
neonat
mice
neutral
antibodi
target
abl
inhibit
reoviru
replic
step
inhibit
either
intern
uncoat
neutral
antibodi
act
block
viru
cell
attach
bind
high
neutral
epitop
specif
antibodi
map
head
domain
viral
escap
mutant
crystal
structur
complex
fab
fragment
antibodi
reveal
case
quaternari
epitop
span
two
fig
bind
site
receptor
distal
antigen
region
engag
reoviru
requir
head
close
approach
cell
membran
two
antibodi
probabl
block
bind
due
steric
hindranc
block
cell
membran
approach
antibodi
also
abl
hinder
reoviru
bind
cell
surfac
carbohydr
indic
hemagglutin
inhibit
assay
antibodi
term
bind
next
site
interact
interfac
around
heavi
chain
contribut
three
time
epitop
light
chain
long
cdr
loop
form
interact
two
residu
involv
glycan
bind
also
involv
bind
sever
aromat
amino
acid
mostli
tyrosin
residu
complementar
determin
region
cdr
form
hydrogen
bond
andor
contribut
bind
via
hydrophob
interact
heavi
chain
cdr
antibodi
partli
occlud
site
thu
directli
block
glycan
receptor
engag
influenza
virus
respons
respiratori
gastrointestin
diseas
pose
signific
challeng
human
health
result
substanti
econom
influenza
virus
belong
famili
orthomyxovirida
envelop
ss
rna
virus
classifi
three
differ
subtyp
accord
serolog
call
flu
human
gener
caus
type
b
influenza
virus
type
respons
sever
diseas
classif
base
two
glycoprotein
project
viral
envelop
hemagglutinin
ha
neuraminidas
na
promin
exampl
ha
major
surfac
glycoprotein
mediat
cell
attach
well
fusion
viru
host
ha
prefus
homotrim
undergo
matur
process
presenc
host
proteas
result
subunit
ha
gener
consist
head
stem
domain
head
domain
includ
pocket
interact
sialic
acid
receptor
host
cell
mediat
head
domain
therefor
import
target
neutral
shown
human
influenza
virus
bind
preferenti
sialyl
glycan
linkag
termin
sialic
acid
gal
avian
virus
hand
prefer
bind
glycan
linkag
posit
ha
head
subject
constant
antigen
drift
enabl
viru
evad
host
immun
respons
residu
make
site
rb
restrict
mutat
freedom
crucial
receptor
recognit
bind
analysi
sequenc
pandem
viru
strain
allow
identifi
mutat
rb
ha
might
import
switch
viru
specif
howev
spanish
flu
pandem
like
caus
pair
mutat
rb
avian
influenza
viru
lead
receptor
switch
link
glycan
therefor
confer
wherea
link
glycan
mainli
found
human
epitheli
cell
trachea
part
upper
respiratori
tract
avian
virus
typic
bind
link
glycan
found
intestin
bird
mutat
one
site
rb
alreadi
confer
dual
bind
link
last
year
number
avail
broadli
neutral
antibodi
bnab
human
influenza
virus
increas
substanti
bnab
show
differ
level
diverg
strain
within
across
subtyp
high
resolut
crystallographi
microscopi
aid
discoveri
supersit
vulner
ha
recogn
bnab
studi
complex
reveal
differ
mode
recognit
accord
antibodi
classifi
two
differ
group
ha
antibodi
recent
discov
ha
antibodi
subgroup
ha
antibodi
antibodi
divid
antibodi
either
recogn
singl
subtyp
heterosubtyp
antibodi
employ
receptor
mimicri
see
small
number
antibodi
display
broader
spectrum
reactiv
heterosubtyp
neutral
exemplifi
receptor
mimicri
antibodi
shown
success
neutral
viru
strain
antibodi
also
employ
receptor
mimicri
similar
addit
show
neutral
activ
broader
rang
strain
includ
pandem
strain
ha
rb
contact
heavi
chain
respons
bind
mode
side
chain
residu
adopt
orient
similar
one
observ
sialic
acid
carboxyl
addit
form
hydrogen
bond
conserv
residu
could
also
observ
broadli
neutral
antibodi
interact
ha
sialyloglycan
therefor
directli
steric
block
heavi
chain
fig
nevertheless
featur
sialoglycan
receptor
mimick
antibodi
receptor
mimicri
spatial
constrain
sinc
rb
allow
interact
one
antibodi
loop
bind
pocket
half
buri
surfac
area
complex
involv
rb
region
adjac
rb
contact
cdr
heavi
light
chain
total
buri
surfac
area
ha
subunit
add
involv
sever
electrostat
mani
van
der
waal
interact
stabil
interfac
conceptu
point
view
bnab
target
rb
special
interest
due
limit
mutat
freedom
residu
form
rb
howev
footprint
ie
surfac
area
cover
sialoglycan
receptor
rb
much
smaller
antibodi
henc
antibodi
block
rb
also
contact
adjac
region
head
region
show
high
divers
sequenc
among
differ
strain
reactiv
antibodi
usual
make
constant
reformul
vaccin
yearli
basi
inevit
norovirus
nov
member
genu
calicivirida
major
caus
acut
viral
gastroenter
form
antigen
divers
group
small
ss
rna
virus
enter
pathogen
usual
associ
diseas
elderli
immunocompromis
suscept
human
nov
link
genet
determin
express
hbga
name
abh
lewi
famili
serv
cell
attach
factor
interact
studi
particl
hbga
reveal
pattern
among
differ
nov
strain
relationship
nov
infect
phenotyp
also
shown
human
volunt
lack
specif
glycosyltransferas
involv
hbga
synthesi
due
silent
allel
lead
polymorph
biosynthesi
antigen
among
human
popul
presenc
function
fucosyltransferas
gene
result
phenotyp
absenc
lead
phenotyp
lack
abh
leb
antigen
saliva
mucos
nov
engag
hbga
subdomain
major
capsid
protein
structur
basi
interact
studi
detail
crystallographi
reveal
local
distinct
site
two
genogroup
gi
gii
also
differ
structur
two
genogroup
includ
human
genotyp
also
refer
norwalk
viru
first
describ
prototyp
strain
gi
nov
genotyp
variant
preval
account
human
nov
infect
major
gi
nov
recogn
well
leb
ley
hbga
nov
abl
bind
lea
contrast
gii
strain
bind
hgba
exhibit
gi
nov
site
involv
residu
antiparallel
form
one
subunit
bind
site
gii
nov
locat
dimer
interfac
involv
two
expos
surfac
loop
site
genogroup
includ
conserv
second
sometim
third
site
prone
mutat
lead
variat
hbga
bind
conserv
site
gi
variant
recogn
gal
lewi
galnac
moieti
wherea
gii
variant
bind
secretor
antigen
lex
ley
strain
within
conserv
site
variabl
site
contribut
less
specif
interact
modul
hgba
specif
review
chang
surfac
expos
variabl
region
nov
believ
driven
select
pressur
immun
system
nov
infect
typic
result
homotyp
adapt
immun
respons
elicit
antibodi
block
hbga
bind
antibodi
shown
play
crucial
role
nov
epitop
map
differ
gi
gii
strain
show
cluster
three
region
outsid
interact
antibodi
human
iga
p
domain
recent
investig
crystallographi
pdb
id
complex
structur
p
domain
reveal
conform
epitop
flank
site
fig
p
domain
residu
site
contact
antibodi
antibodi
recognit
alter
orient
site
nevertheless
model
simultan
glycan
receptor
bind
p
domain
indic
antibodi
directli
block
hbga
engag
p
domain
heavi
chain
occlud
site
clash
carbohydr
moieti
glycan
thu
like
mechan
antibodi
neutral
direct
steric
hindranc
alloster
disrupt
site
blockad
via
bind
residu
cov
belong
famili
coronavirida
envelop
ss
rna
virus
caus
respiratori
enter
hepat
neuron
infecti
diseas
anim
human
classifi
four
genera
cov
possess
trimer
envelop
spike
glycoprotein
respons
receptor
bind
membran
fusion
viral
protein
organ
domain
domain
transmembran
region
intracellular
domain
rbd
part
domain
determin
cellular
tropism
domain
mediat
cov
differ
substanti
rbd
regard
sequenc
structur
consequ
recogn
differ
entri
receptor
virus
show
complex
receptor
recognit
pattern
even
highli
similar
cov
genu
recogn
differ
novel
cov
middl
east
respiratori
syndrom
cov
first
identifi
june
infect
caus
symptom
sever
pneumonia
septic
shock
failur
mani
case
fatal
http
wwwwhointemergenciesmerscoven
far
specif
treatment
vaccin
cov
avail
due
epidem
pandem
potenti
emerg
cov
urgent
need
medic
util
human
dipeptidyl
peptidas
also
known
cellular
receptor
exhibit
neither
structur
signific
sequenc
similar
previous
identifi
cov
receptor
carcinoembryon
adhes
molecul
receptor
mous
hepat
viru
aminopeptidas
n
receptor
sever
howev
import
glycosyl
receptor
recognit
specif
common
receptor
number
cov
differ
genera
infect
mice
pig
bird
use
sialic
acid
attach
multifunct
glycoprotein
highli
conserv
among
mammal
play
import
role
activ
glucos
metabol
structur
contain
consist
eight
blade
structur
analys
complex
protein
show
contact
rbd
blade
bind
interfac
reveal
seri
residu
critic
interact
involv
hydrophil
residu
form
polar
network
well
three
hydrophob
cov
glycosyl
receptor
import
bind
crystal
structur
complex
pdb
code
trisaccharid
attach
contact
rbd
well
first
nag
residu
glycan
moieti
form
hydrogen
bond
rbd
second
nag
stack
onto
aromat
ring
third
mannos
residu
contact
via
hydrogen
interact
crucial
bind
viral
entri
sinc
use
singl
cellular
receptor
viral
entri
agent
capabl
block
interact
would
promis
candid
block
entri
viru
target
shown
monoclon
polyclon
antibodi
direct
inhibit
infect
differ
cell
play
import
role
multipl
cellular
process
antibodi
may
howev
caus
unwant
side
reaction
henc
antibodi
target
rbd
addit
shown
anim
model
entri
could
inhibit
polyclon
antibodi
studi
fortifi
hypothesi
antibodi
direct
rbd
might
effici
block
entri
recent
two
neutral
antibodi
librari
screen
approach
rbd
antibodi
also
shown
inhibit
vitro
infect
live
pseudovirus
make
potenti
candid
combat
far
crystal
structur
complex
bound
avail
pdb
code
complex
heavi
light
chain
interact
rbd
bind
epitop
show
small
overlap
bind
epitop
yet
insert
carbohydr
moieti
caviti
heavi
light
chain
complet
disrupt
interact
rbd
receptor
fig
henc
would
prevent
engag
part
clash
attach
receptor
virus
pose
constant
threat
human
health
substanti
econom
burden
identifi
character
viral
receptor
defin
mechan
viru
attach
intern
improv
understand
infect
process
viral
replic
cycl
mechanist
knowledg
ultim
inform
strategi
antivir
exampl
target
interfer
attach
releas
neutral
antibodi
play
central
role
natur
protect
viral
infect
character
antibodi
patient
surviv
diseas
exampl
ebola
viru
diseas
demonstr
vast
therapeut
potenti
howev
understand
neutral
yet
reach
level
allow
us
fulli
exploit
potenti
therapi
vaccin
structur
analysi
bnab
bind
epitop
viral
surfac
help
advanc
understand
ultim
develop
individu
antivir
strategi
review
focus
four
human
virus
contain
protrud
attach
protein
structur
data
glycan
receptor
neutral
antibodi
bind
avail
rbss
spike
distal
viru
particl
therefor
often
part
direct
proxim
epitop
recogn
neutral
antibodi
seem
intuit
rbss
epitop
antibodi
recognit
benefit
facil
access
respect
region
viru
particl
also
antibodi
prevent
simultan
receptor
bind
via
steric
hindranc
particularli
effici
immunolog
tool
therefor
perhap
surpris
receptor
site
four
virus
discuss
articl
overlap
mani
case
comparison
show
often
direct
glycan
receptor
mimicri
employ
antibodi
partial
reoviru
complet
cov
block
site
common
featur
complex
effici
neutral
also
observ
antibodi
bind
immedi
vicin
show
overlap
site
noroviru
case
antibodi
possess
conform
epitop
common
characterist
neutral
antibodi
special
case
quaternari
epitop
span
multipl
subunit
seen
exampl
antibodi
site
bridg
two
subunit
juxtaposit
residu
respons
glycan
engag
found
singl
monom
obviou
requir
subunit
bridg
abil
antibodi
block
glycan
bind
bridg
might
well
prevent
conform
chang
viral
attach
protein
later
entri
step
well
establish
envelop
virus
antibodi
found
stabil
state
viru
therebi
prevent
conform
chang
requir
receptor
bind
membran
fusion
exampl
neutral
antibodi
target
lassa
viru
monoclon
antibodi
dengu
biochem
point
view
profound
differ
glycan
antibodi
respect
first
rel
size
also
physiolog
context
interact
occur
virus
bind
individu
glycan
receptor
rel
low
affin
often
mm
use
limit
number
contact
local
densiti
glycoconjug
exampl
gangliosid
plasma
membran
high
low
individu
bind
energi
typic
enhanc
engag
multipl
receptor
copi
time
low
affin
overcom
high
avid
antibodi
hand
need
high
affin
least
nm
virion
surfac
antigen
mediat
effici
neutral
part
particular
compar
glycan
bind
due
limit
number
compar
larg
antibodi
simultan
engag
viral
spike
protein
without
clash
thu
locat
glycan
rbss
antibodi
epitop
viral
capsid
may
often
overlap
least
part
aspect
interact
fundament
differ
fig
footprint
antibodi
gener
significantli
roughli
three
time
larger
footprint
glycan
make
around
contact
form
cdr
gener
larg
fraction
cdr
compris
aromat
residu
tryptophan
tyrosin
whose
antigen
interact
therefor
base
hydrophob
aromat
hydrophil
charact
glycan
also
reli
differ
type
interact
facilit
protein
bind
depend
orient
function
group
face
glycan
ring
exhibit
differ
pattern
hydrophob
hydrophil
particip
hydrogen
bond
van
der
waal
interact
well
hydrophob
interact
glycan
receptor
mimicri
antibodi
probabl
limit
due
geometr
spatial
restraint
cdr
one
rare
exampl
glycan
receptor
mimicri
antibodi
target
rb
ha
human
influenza
viru
although
would
perhap
easier
antibodi
mimic
proteinac
viru
receptor
search
literatur
yield
mani
exampl
strategi
promin
case
hiv
receptor
induc
profound
structur
chang
hiv
envelop
protein
antibodi
mimic
elicit
chang
therebi
render
vulner
immun
system
howev
situat
hiv
like
uniqu
bind
glycan
protein
receptor
normal
trigger
massiv
conform
chang
viral
attach
protein
fact
case
review
structur
chang
occur
upon
glycan
bind
minim
antibodi
larger
far
protein
receptor
may
need
exactli
mimic
receptor
bind
order
achiev
neutral
appear
bind
anywher
vicin
receptor
suffici
would
readili
prevent
access
viru
receptor
case
